Literature DB >> 15627742

Phosphate kinetics during different dialysis modalities.

Ranistha Ratanarat1, Alessandra Brendolan, Gopel Volker, Monica Bonello, Gabriella Salvatori, Emilio Andrikos, Asuman Yavuz, Carlo Crepaldi, Claudio Ronco.   

Abstract

BACKGROUND: An abnormal serum phosphate concentration is common in acute renal failure patients, with a reported incidence of 65-80%. Phosphate removal and kinetics during intermittent hemodialysis (IHD) have been investigated, but there is no information on its kinetics during slow low-efficiency dialysis (SLED) and continuous renal replacement therapy (CRRT).
METHODS: Eight IHD, 8 SLED, and 10 continuous venovenous hemofiltration (CVVH) patients with a residual renal clearance of <4.0 ml/min were studied during a single treatment to evaluate phosphate removal and kinetics. CVVH was studied the first 24 h after initiation. Dialysis/replacement fluid contained no phosphate. Kt/V, clearance of urea (Ku), inorganic phosphate (Kp) and solute removal was determined by direct dialysate quantification (DDQ).
RESULTS: Kp recorded with the three techniques were: IHD, 126.9 +/- 18.4 ml/min; SLED, 58.0 +/- 15.8 ml/min, and CVVH, 31.5 +/- 6.0 ml/min. However, in shorter dialysis treatment the total removal of phosphate was significantly lower than in longer dialysis (IHD, 29.9 +/- 7.7 mmol; SLED, 37.6 +/- 9.6 mmol; CVVH, 66.7 +/- 18.9 mmol, p = 0.001). The duration of treatment is the only factor determining phosphate removal (r = 0.7, p < 0.0001 by linear correlation model). Like IHD, phosphate kinetics during SLED could not be explained by the two-pool kinetic model, and the rebound of phosphate extended beyond 1 h after dialysis. Rebound, however, is less marked than in short dialysis.
CONCLUSION: These results are reliable evidence about amount of phosphate removal and behavior of intradialytic phosphate kinetics in renal failure patients undergoing different dialysis modalities. These data will help clinicians plan phosphate supplementation and treatment intensity. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15627742     DOI: 10.1159/000082016

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Intensity of Renal Replacement Therapy and Duration of Mechanical Ventilation: Secondary Analysis of the Acute Renal Failure Trial Network Study.

Authors:  Shilpa Sharma; Yvelynne P Kelly; Paul M Palevsky; Sushrut S Waikar
Journal:  Chest       Date:  2020-05-26       Impact factor: 9.410

2.  Phosphate balance in continuous venovenous hemofiltration.

Authors:  Shilpa Sharma; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-22       Impact factor: 8.860

3.  Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Authors:  Baris U Agar; Alp Akonur; Ying-Cheng Lo; Alfred K Cheung; John K Leypoldt
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

Review 4.  Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies.

Authors:  Valentina Pistolesi; Laura Zeppilli; Enrico Fiaccadori; Giuseppe Regolisti; Luigi Tritapepe; Santo Morabito
Journal:  J Nephrol       Date:  2019-09-12       Impact factor: 3.902

5.  Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacment therapy.

Authors:  Shilpa Sharma; Carlo Brugnara; Rebecca A Betensky; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-23       Impact factor: 8.237

6.  Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury.

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Int Urol Nephrol       Date:  2012-01-07       Impact factor: 2.370

7.  Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events.

Authors:  Cynthia Lim; Han Khim Tan; Manish Kaushik
Journal:  Clin Kidney J       Date:  2017-01-05

8.  Application of dynamic optimisation for planning a haemodialysis process.

Authors:  Wojciech Stecz; Radoslaw Pytlak; Aleksandra Rymarz; Stanislaw Niemczyk
Journal:  BMC Nephrol       Date:  2019-07-02       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.